🇺🇸 FDA
Pipeline program

Endoscopic submucosal dissection

CRE-2009.625

Phase 3 other active

Quick answer

Endoscopic submucosal dissection for Colorectal Neoplasms is a Phase 3 program (other) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Colorectal Neoplasms
Phase
Phase 3
Modality
other
Status
active

Clinical trials